Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals (CEL)

Company name:Celadon Pharmaceuticals Plc
EPIC:CELTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BDQYGP38
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.celadonpharma.com/Description:ORD 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 53.50 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 52.00 55.00 53.50 53.50 53.50 17
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 87.52 163.59 -0.02 -9.60 - - - 162.50 - 49.00

Celadon Pharmaceuticals Key Figures

(at previous day's close)
Market Cap.87.52m
Shares In Issue163.59m
Prev. Close53.50
PE Ratio- 
Dividend Yield-%
EPS - basic-9.60p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.66p
Return On Equity (ROE)-11.24%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-236.84%
Dividends PS Growth Rate-%
Net Debt-4.27m
Gross Gearing2.98%
Quick Assets6.61m
Net Working Capital6.43m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-0.44p
Retained Profit PS-0.44p
Cash PS2.73p
Net Cash PS2.62p
Net Tangible Asset Value PS *3.92p
Net Asset Value PS3.92p
Spread3.00 (5.45%) 

Celadon Pharmaceuticals Balance Sheet


Share Price Performance

Sample Period HighLow
1 week53.5053.50
4 weeks59.5049.50
12 weeks59.5049.50
1 year162.5049.00

Share Price Chart (5 years)

Celadon Pharmaceuticals Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week53.50--53.500.0553.50
4 weeks49.504.008.0849.500.1452.72
12 weeks49.504.008.0849.500.0752.60
26 weeks80.50-27.00-33.5449.000.0558.84
1 year162.50-109.00-67.0849.000.0588.60
3 years85.00-31.50-37.0649.000.05157.06
5 years102.50-49.00-47.8049.000.05157.03

Celadon Pharmaceuticals Key Management Ratios

Celadon Pharmaceuticals Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 14.46 
Tobin's Q Ratio (excl. intangibles)14.46 
Dividend Yield-%
Market-to-Book Ratio13.65 
Price-to-Pre-Tax Profit PS-121.50 
Price-to-Retained Profit PS-121.50 
Price-to-Cash Flow PS-32.32 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS13.65 
Price-to-Cash PS19.61 
Net Working Capital PS3.93 
Price Pct to Working Capital PS13.61%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Celadon Pharmaceuticals Financial Ratios

(Leverage Ratios)
Debt Ratio0.32%
Debt-to-Equity Ratio0.00 
Debt-to-Equity Ratio (excl. Intgbl)0.00 
Debt-to-Equity Market Value0.00 
Net Gearing-64.55%
Net Gearing (excl. Intangibles)-64.55%
Gross Gearing2.98%
Gross Gearing (excl. Intangibles)2.98%
Gearing Under 1 Year2.68%
Gearing Under 1 Year (excl. Intgbl)2.68%
(Liquidity Ratios)
Net Working Capital to Total Assets97.32%
Current Ratio37.35 
Quick Ratio (Acid Test)37.35 
Liquidity Ratio25.22 
Cash & Equiv/Current Assets67.54%
(Solvency Ratios)
Enterprise Value83.08m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.00 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.27 
Total Debt0.20m
Total Debt/Net Current Assets0.03%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)

Celadon Pharmaceuticals Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-11.20%
Return On Assets (ROA)-11.90%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-11.24%
Return On Investment (ROI)-12.11%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Celadon Pharmaceuticals Dividends

Sorry No Data Available

Celadon Pharmaceuticals Fundamentals

 31 Aug 2019 (GBP)31 Aug 2020 (GBP)31 Dec 2021 (GBP)
pre tax profit-0.19--0.17--0.72-m
attributable profit-0.19--0.17--0.72-m
retained profit-0.19--0.17--0.72-m
eps - basic (p)-3.60 -2.85 -9.60 
eps - diluted (p)-3.60 -2.85 -9.60 
dividends per share- - - 

Celadon Pharmaceuticals Balance Sheet

 31 Aug 2019 (GBP)31 Aug 2020 (GBP)31 Dec 2021 (GBP)
 31 Aug 2019 (GBP)31 Aug 2020 (GBP)31 Dec 2021 (GBP)
fixed assets fixed assets--%--%--%m
intangibles intangibles--%--%--%m
fixed investments fixed investments--%--%--%m
current assets - other current assets - other--%--%--%m
stocks stocks--%--%--%m
debtors debtors0.020.28%0.010.18%2.1432.46%m
cash & securities cash & securities5.6599.72%5.4999.82%4.4667.54%m
creditors - short creditors - short0.020.37%0.030.54%0.182.68%m
creditors - long creditors - long0.010.21%0.010.22%0.020.31%m
creditors - other creditors - other--%--%--%m
subordinated loans subordinated loans--%--%--%m
insurance funds insurance funds--%--%--%m
ord cap, reserves ord cap, reserves5.6399.42%5.4699.24%6.4197.02%m
prefs, minorities prefs, minorities--%--%--%m
NAV Basic- - - 
NAV Diluted- - - 

Celadon Pharmaceuticals Cash Flow Statement

31 Aug 2019 (GBP)31 Aug 2020 (GBP)31 Dec 2021 (GBP)
Operating CF-0.17-0.16-2.71m
Pre-Financing CF-0.17-0.16-2.71m
Retained CF5.65-0.16-1.03m

Celadon Pharmaceuticals Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Piper Jaffray LtdMarket Maker(MMF)Broker/DealerPIPRPIPRGB21
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Merrill Lynch InternationalMarket Maker(MMF)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
Celadon Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230209 10:37:43